Sanofi SA (SNY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

54 RUE LA BOETIE PARIS, FRANCE 75008

Sanofi is an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Pharmaceuticals segment covers research, development, production and marketing of medicines. The Vaccines segment is wholly dedicated to vaccines, including research, development, production and marketing. This segment includes Co.'s Sanofi Pasteur MSD joint venture with Merck & Co., Inc. in Europe. The Animal Health segment comprises the research, development, production and marketing activities of Merial, which offers a complete range of medicines and vaccines for a wide variety of animal species.

Data as of 2020-05-30
Market Cap122.981 Billion Shares Outstanding2.504 Billion Avg 30-day Volume1.965 Million
P/E Ratio31.3 Dividend Yield3.46 EPS2.01
Price/Sales3.217 Price cash flow ratio13.9 Price free cash flow ratio182.4
Book Value25.93 Price to Tangible Book Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.267981
BETA0.614792 52-week High/Low51.84 / 37.62 Stddev0.050685
View SEC Filings from SNY instead.

Funds Holding SNY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SNY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History

Holder Net Short Position Position Date Origin
BRIDGEWATER ASSOCIATES, LP SANOFI 0.5% 2018-02-28 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.66% 2018-03-23 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.59% 2018-02-07 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.56% 2018-04-06 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.58% 2018-02-14 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.72% 2018-02-09 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.62% 2018-02-06 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.64% 2018-02-12 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.49% 2018-04-10 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.5% 2018-02-05 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.49% 2018-02-20 FRANCE
BRIDGEWATER ASSOCIATES, LP SANOFI 0.65% 2018-02-08 FRANCE

Elevate your investments